GlassScriptPhysician profile
Erin Mcdonough
NPI 1073964268
$13,162.26
in general payments reported to CMS, 2019-2025
71 companies · $3,571 in 2025
The $3,571 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,301 · 2022: $1,955 · 2023: $3,171 · 2024: $3,164 · 2025: $3,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,731 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,730.85 |
| Education | $175.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $887.50 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Novartis Pharmaceuticals Corporation | $877.67 | 2021-2025 | Kisqali, Piqray |
| Janssen Biotech, INC. | $804.83 | 2021-2025 | Darzalex, Tecvayli, Rybrevant |
| Pfizer INC. | $739.93 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $622.45 | 2021-2025 | Imfinzi, Enhertu, Calquence |
| Merck Sharp & Dohme LLC | $559.42 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $505.96 | 2021-2025 | |
| Incyte Corporation | $485.71 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Gilead Sciences, INC. | $446.31 | 2021-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $352.95 | 2021-2025 | |
| Seagen INC. | $347.35 | 2021-2023 | Padcev, Tivdak, Adcetris |
| Genzyme Corporation | $330.52 | 2021-2025 | |
| Lilly USA, LLC | $313.67 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Regeneron Healthcare Solutions, INC. | $307.88 | 2021-2025 | Libtayo |
| Astellas Pharma US INC | $303.16 | 2021-2025 | Padcev, Xtandi, Xospata |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $296.73 | 2023-2025 | Enhertu, Datroway |
| Blueprint Medicines Corporation | $285.82 | 2022-2025 | Ayvakit |
| Abbvie INC. | $234.09 | 2024-2025 | |
| Amgen INC. | $225.66 | 2021-2023 | Kyprolis, Blincyto |
| Glaxosmithkline, LLC. | $222.87 | 2023-2025 | Ojjaara, Jemperli, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $218.70 | 2022-2025 | Opdivo, Krazati, Opdualag |
| Takeda Pharmaceuticals U.S.A., INC. | $185.69 | 2023-2024 | Alunbrig, Fruzaqla, Hyqvia |
| Kite Pharma, INC. | $172.86 | 2022-2025 | Yescarta |
| Emd Serono, INC. | $161.71 | 2021-2025 | Bavencio |
| Exelixis INC. | $157.51 | 2022-2023 | Cabometyx |
| Genmab U.S., INC. | $157.27 | 2023-2025 | Epkinly |
| Pharmacyclics LLC, An Abbvie Company | $150.17 | 2021-2023 | Imbruvica |
| Stemline Therapeutics INC. | $137.17 | 2023-2025 | Orserdu |
| Karyopharm Therapeutics INC. | $133.60 | 2023-2024 | Xpovio |
| Jazz Pharmaceuticals INC. | $123.90 | 2021-2025 | |
| Genentech USA, INC. | $121.80 | 2022-2024 | Venclexta, Lunsumio, Gazyva |
| Pharmacosmos Therapeutics INC. | $120.66 | 2021-2025 | Monoferric, Cosela |
| Puma Biotechnology, INC. | $120.25 | 2021-2025 | |
| Celgene Corporation | $117.72 | 2024-2025 | Reblozyl |
| Mirati Therapeutics, INC. | $115.82 | 2023-2024 | Krazati |
| Sumitomo Pharma America, INC. | $113.46 | 2023-2025 | Orgovyx |
| Alexion Pharmaceuticals, INC. | $110.16 | 2023-2025 | Ultomiris |
| Array Biopharma INC | $109.15 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
| Legend Biotech USA INC. | $96.75 | 2025 | Carvykti |
| Taiho Oncology, INC. | $89.65 | 2023-2024 | |
| Beigene USA, INC. | $86.48 | 2022-2025 | Brukinsa, Tevimbra |
| Deciphera Pharmaceuticals INC. | $78.05 | 2023-2024 | Qinlock |
| Sobi, INC | $77.75 | 2024-2025 | |
| Cti Biopharma Corp. | $75.79 | 2022-2023 | Vonjo |
| Recordati_rare_diseases_inc. | $62.05 | 2022-2025 | Enjaymo, Panhematin |
| Ipsen Biopharmaceuticals, INC | $59.70 | 2021-2025 | Somatuline Depot, Onivyde |
| Csl Behring | $57.53 | 2022-2023 | Idelvion, Afstyla |
| G1 Therapeutics, INC. | $54.33 | 2022-2023 | Cosela |
| Kyowa Kirin, INC. | $54.31 | 2025 | |
| Myovant Sciences INC. | $52.98 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $51.71 | 2022-2025 | Givlaari |
| Geron Corporation | $50.34 | 2025 | Rytelo |
| Adc Therapeutics America, INC. | $49.98 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.76 | 2021-2022 | |
| Pharmaessentia USA Corporation | $42.10 | 2022-2023 | Besremi |
| Agios Pharmaceuticals, INC. | $38.24 | 2021-2025 | Pyrukynd |
| Tersera Therapeutics LLC | $35.69 | 2025 | Zoladex |
| Dendreon Pharmaceuticals LLC | $34.12 | 2023 | Provenge |
| Janssen Pharmaceuticals, INC | $31.83 | 2021-2024 | Xarelto |
| Blue Earth Diagnostics | $31.42 | 2022 | |
| Ge Healthcare | $27.68 | 2022 | |
| Immunocore Limited | $27.44 | 2025 | Kimmtrak |
| Aveo Pharmaceuticals, INC. | $22.06 | 2023 | Fotivda |
| Syndax Pharmaceuticals, INC. | $21.99 | 2025 | Revuforj |
| Tg Therapeutics, INC. | $21.36 | 2021 | |
| Dova Pharmaceuticals | $20.70 | 2021 | |
| Telix Pharmaceuticals | $19.30 | 2023 | Illuccix |
| Iovance Biotherapeutics, INC. | $18.60 | 2025 | Amtagvi |
| Eusa Pharma (US) LLC | $17.98 | 2022 | |
| Acrotech Biopharma INC. | $17.16 | 2022 | |
| Spectrum Pharmaceuticals INC. | $15.35 | 2023 | Rolvedon |
Drugs and devices associated with these payments
Tavalisse $745Rezlidhia $745Keytruda $411Enhertu $378Gavreto $355Lenvima $325Padcev $287Jakafi $262Imbruvica $253Kisqali $246Libtayo $231Nubeqa $222Ayvakit $216Darzalex $213Lynparza $189Tukysa $186Ojjaara $182Xofigo $177Tecvayli $158Epkinly $157Elrexfio $149Krazati $149Yescarta $148Rybrevant $147Reblozyl $145Monjuvi $143Imfinzi $142Jaypirca $141Trodelvy $140Venclexta $140Orserdu $137Vonjo $136Xpovio $134Erleada $133Bosulif $129Orgovyx $128Carvykti $125Pluvicto $125Ibrance $122Tivdak $122Fabhalta $121Verzenio $121Adcetris $114Ultomiris $110Sarclisa $109Braftovi $109Stivarga $104Vitrakvi $104Xtandi $97.16Alunbrig $96.29Zepzelca $93.05Inqovi $89.65Lonsurf $89.65Mektovi $86.81Retevmo $85.32Piqray $80.37Qinlock $78.05Cosela $73.03Monoferric $66.99Inlyta $66.96Promacta $66.46Lorbrena $61.95Opdivo $61.59Fruzaqla $56.16Datroway $54.91Poteligeo $54.31Talvey $53.11Zynyz $52.22Rytelo $50.34Zynlonta $49.98Besponsa $49.59Enjaymo $48.35Scemblix $47.95Cabometyx $45.83Welireg $44.49Somatuline Depot $42.46Onivyde $42.46Emrelis $41.58Brukinsa $38.88Illuccix $38.60Zoladex $35.69Xospata $34.61Provenge $34.12Hyqvia $33.24Bavencio $31.94Paxlovid $31.45Idelvion $31.11Afstyla $31.11Givlaari $29.29Tevimbra $28.14Lunsumio $27.91Gazyva $27.91Kimmtrak $27.44Kyprolis $25.26Blincyto $25.26Opdualag $25.19Akeega $25.04Pyrukynd $23.22Jemperli $23.20Fotivda $22.06
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Mcdonough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.